Keyphrases
Acute Myeloid Leukemia
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
79%
Granulocyte Colony-stimulating Factor (G-CSF)
58%
CD34+
43%
Marrow
41%
Leukemia
38%
Myelodysplastic Syndrome
35%
Relapsed or Refractory
31%
CSF-1
30%
Phase II Study
29%
CD34+ Cells
28%
Cytarabine
27%
Graft-versus-host Disease (GvHD)
26%
Chronic Myeloid Leukemia
23%
Plerixafor
21%
Decitabine
21%
Complete Remission
20%
Event-free Survival
19%
Interleukin-1β
18%
Progenitor Cells
18%
Neutrophils
18%
Phase I Study
18%
Adhesion
17%
Relapsed or Refractory Acute Myeloid Leukemia
17%
Etoposide
17%
Chemokines
16%
Chemotherapy
16%
Human Bone Marrow
16%
HL-60 Cells
15%
Herpes Simplex Virus Thymidine Kinase
15%
Tumor Cells
15%
Leukemia Patients
15%
Leukemic Cells
14%
Tumor Necrosis Factor-α
14%
Integrin
14%
Stromal Cells
13%
Azacitidine
13%
Erythroid
13%
Lymphoma Patients
13%
NCCN Guidelines
13%
Stimulating Activities
13%
CFU-GM
13%
Overall Survival
12%
Growth Factors
12%
Natural Killer Cells
12%
Human B Cells
12%
Cell Co-culture
11%
Endothelial Cells
11%
Multiple Myeloma
11%
B-cell Precursors
11%
Immunology and Microbiology
CD34
69%
Myeloid
46%
Hematopoietic Cell
42%
Cytokine
35%
Granulocyte Macrophage Colony-Stimulating Factor
25%
Plerixafor
23%
Stem Cell
22%
Cell Transplantation
22%
Cell Line
21%
Granulocyte
18%
Precursor
18%
Immunology
17%
Tumor Cell
17%
B Cell
16%
Chemokine
16%
Coculture
15%
Colony Forming Unit S
15%
Macrophage
15%
Herpes Simplex Virus
15%
Cyclophosphamide
14%
Colony-Forming Unit
14%
Integrin
14%
Tumor Necrosis Factor
14%
Stroma
13%
Fibroblast
13%
Granulocyte Colony-Stimulating Factor
13%
Natural Killer Cell
12%
Drug Megadose
11%
Neutrophil
11%
Colony Stimulating Factor
11%
Leukemia Cell
10%
Multiple Myeloma
10%
Autotransplantation
10%
Graft-Versus-Host Disease
10%
Interleukin 7
10%
Monoclonal Antibody
9%
T Cell
9%
Cytomegalovirus
9%
Bystander Effect
9%
Human Immunodeficiency Virus
9%
Event Free Survival
9%
Conditioning
8%
Stem Cell Transplant
8%
Lineages
8%
RANTES
8%
Stem Cell Factor
8%
Caspase
8%
Secretion (Process)
7%
Cancer Growth Factor
7%
Interleukin 1
7%
Medicine and Dentistry
Acute Myeloid Leukemia
70%
Hematopoietic Cell
27%
Disease
27%
Myelodysplastic Syndrome
23%
Chronic Myelogenous Leukemia
21%
Cytarabine
20%
Chemotherapy
19%
Cytokine
19%
Stem Cell Transplant
18%
Transplantation
17%
In Vitro
17%
Colony Forming Unit S
16%
Leukemia
15%
Event Free Survival
15%
Decitabine
14%
Cell Transplantation
14%
Etoposide
13%
Plerixafor
13%
Adhesive Agent
13%
Progenitor Cell
12%
Granulocyte Macrophage Colony Stimulating Factor
12%
Myeloid Leukemia
12%
Carmustine
11%
Drug Megadose
11%
Allogeneic Stem Cell Transplantation
11%
Integrin
11%
Tyrosine-Kinase Inhibitor
11%
Autotransplantation
10%
Overall Survival
10%
Azacitidine
10%
Stem Cell Factor
10%
Granulocyte Colony Stimulating Factor
10%
Precursor
9%
Stroma
9%
Leukemia Cell
9%
Eosinophil
9%
Stem Cell
9%
Acute Graft Versus Host Disease
9%
Autologous Stem Cell Transplantation
9%
Graft Versus Host Reaction
9%
Acute Leukemia
8%
Prognostic Factor
8%
Acute Myelogenous Leukemia
8%
Donor Lymphocyte Infusion
8%
Oncology
8%
Cyclophosphamide
8%
Tumor Necrosis Factor
8%
Neutrophil
8%
Neoplasm
7%
Placebo
7%
